Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 130

1.

The synthetic peptide P111-136 derived from the C-terminal domain of heparin affin regulatory peptide inhibits tumour growth of prostate cancer PC-3 cells.

Hamma-Kourbali Y, Bermek O, Bernard-Pierrot I, Karaky R, Martel-Renoir D, Frechault S, Courty J, Delbé J.

BMC Cancer. 2011 May 30;11:212. doi: 10.1186/1471-2407-11-212.

2.

Dominant negative effectors of heparin affin regulatory peptide (HARP) angiogenic and transforming activities.

Bernard-Pierrot I, Delbé J, Rouet V, Vigny M, Kerros ME, Caruelle D, Raulais D, Barritault D, Courty J, Milhiet PE.

J Biol Chem. 2002 Aug 30;277(35):32071-7. Epub 2002 Jun 17.

3.

Heparin affin regulatory peptide/pleiotrophin negatively affects diverse biological activities in C6 glioma cells.

Parthymou A, Lampropoulou E, Mikelis C, Drosou G, Papadimitriou E.

Eur J Cell Biol. 2008 Jan;87(1):17-29. Epub 2007 Sep 18.

PMID:
17881084
4.

A basic peptide derived from the HARP C-terminus inhibits anchorage-independent growth of DU145 prostate cancer cells.

Bermek O, Diamantopoulou Z, Polykratis A, Dos Santos C, Hamma-Kourbali Y, Burlina F, Delbé J, Chassaing G, Fernig DG, Katsoris P, Courty J.

Exp Cell Res. 2007 Nov 15;313(19):4041-50. Epub 2007 Aug 7.

PMID:
17727841
5.

Heparin affin regulatory peptide binds to vascular endothelial growth factor (VEGF) and inhibits VEGF-induced angiogenesis.

Héroult M, Bernard-Pierrot I, Delbé J, Hamma-Kourbali Y, Katsoris P, Barritault D, Papadimitriou E, Plouet J, Courty J.

Oncogene. 2004 Mar 4;23(9):1745-53.

PMID:
15001987
6.

A Pleiotrophin C-terminus peptide induces anti-cancer effects through RPTPβ/ζ.

Diamantopoulou Z, Bermek O, Polykratis A, Hamma-Kourbali Y, Delbé J, Courty J, Katsoris P.

Mol Cancer. 2010 Aug 25;9:224. doi: 10.1186/1476-4598-9-224.

7.

Heparin affin regulatory peptide is a key player in prostate cancer cell growth and angiogenicity.

Hatziapostolou M, Delbe J, Katsoris P, Polytarchou C, Courty J, Papadimitriou E.

Prostate. 2005 Oct 1;65(2):151-8.

PMID:
15924335
8.

Involvement of heparin affin regulatory peptide in human prostate cancer.

Vacherot F, Caruelle D, Chopin D, Gil-Diez S, Barritault D, Caruelle JP, Courty J.

Prostate. 1999 Feb 1;38(2):126-36.

PMID:
9973098
9.

Mitogenic and in vitro angiogenic activity of human recombinant heparin affin regulatory peptide.

Laaroubi K, Delbé J, Vacherot F, Desgranges P, Tardieu M, Jaye M, Barritault D, Courty J.

Growth Factors. 1994;10(2):89-98.

PMID:
7520717
10.

Small molecule tolfenamic acid inhibits PC-3 cell proliferation and invasion in vitro, and tumor growth in orthotopic mouse model for prostate cancer.

Sankpal UT, Abdelrahim M, Connelly SF, Lee CM, Madero-Visbal R, Colon J, Smith J, Safe S, Maliakal P, Basha R.

Prostate. 2012 Nov;72(15):1648-58. doi: 10.1002/pros.22518. Epub 2012 Apr 2.

PMID:
22473873
11.

Characterization of heparin affin regulatory peptide signaling in human endothelial cells.

Polykratis A, Katsoris P, Courty J, Papadimitriou E.

J Biol Chem. 2005 Jun 10;280(23):22454-61. Epub 2005 Mar 28.

12.

Identification of heparin affin regulatory peptide domains with potential role on angiogenesis.

Polykratis A, Delbé J, Courty J, Papadimitriou E, Katsoris P.

Int J Biochem Cell Biol. 2004 Oct;36(10):1954-66.

PMID:
15203110
13.

A peptide corresponding to the C-terminal region of pleiotrophin inhibits angiogenesis in vivo and in vitro.

Mikelis C, Lamprou M, Koutsioumpa M, Koutsioubas AG, Spyranti Z, Zompra AA, Spiliopoulos N, Vradis AA, Katsoris P, Spyroulias GA, Cordopatis P, Courty J, Papadimitriou E.

J Cell Biochem. 2011 Jun;112(6):1532-43. doi: 10.1002/jcb.23066.

PMID:
21344482
14.

Proliferation and migration activities of fibroblast growth factor-2 in endothelial cells are modulated by its direct interaction with heparin affin regulatory peptide.

Dos Santos C, Blanc C, Elahouel R, Prescott M, Carpentier G, Ori A, Courty J, Hamma-Kourbali Y, Fernig DG, Delbé J.

Biochimie. 2014 Dec;107 Pt B:350-7. doi: 10.1016/j.biochi.2014.10.002. Epub 2014 Oct 12.

PMID:
25315978
15.

Effects of cloned tumstatin-related and angiogenesis-inhibitory peptides on proliferation and apoptosis of endothelial cells.

Zhang GM, Zhang YM, Fu SB, Liu XH, Fu X, Yu Y, Zhang ZY.

Chin Med J (Engl). 2008 Nov 20;121(22):2324-30.

PMID:
19080341
16.

Diallyl trisulfide suppresses growth of PC-3 human prostate cancer xenograft in vivo in association with Bax and Bak induction.

Xiao D, Lew KL, Kim YA, Zeng Y, Hahm ER, Dhir R, Singh SV.

Clin Cancer Res. 2006 Nov 15;12(22):6836-43.

17.

Effect of heparin on bovine epithelial lens cell proliferation induced by heparin affin regulatory peptide.

Delbé J, Vacherot F, Laaroubi K, Barritault D, Courty J.

J Cell Physiol. 1995 Jul;164(1):47-54.

PMID:
7790396
18.

Inhibition of the mitogenic, angiogenic and tumorigenic activities of pleiotrophin by a synthetic peptide corresponding to its C-thrombospondin repeat-I domain.

Hamma-Kourbali Y, Bernard-Pierrot I, Heroult M, Dalle S, Caruelle D, Milhiet PE, Fernig DG, Delbé J, Courty J.

J Cell Physiol. 2008 Jan;214(1):250-9.

PMID:
17607711
19.

The lysine-rich C-terminal tail of heparin affin regulatory peptide is required for mitogenic and tumor formation activities.

Bernard-Pierrot I, Delbe J, Caruelle D, Barritault D, Courty J, Milhiet PE.

J Biol Chem. 2001 Apr 13;276(15):12228-34. Epub 2001 Jan 9.

20.

16-kDa fragment of pleiotrophin acts on endothelial and breast tumor cells and inhibits tumor development.

Ducès A, Karaky R, Martel-Renoir D, Mir L, Hamma-Kourbali Y, Biéche I, Opolon P, Delbé J, Courty J, Perricaudet M, Griscelli F.

Mol Cancer Ther. 2008 Sep;7(9):2817-27. doi: 10.1158/1535-7163.MCT-08-0301.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk